5 Most Promising Gene Editing Stocks According to Hedge Funds

In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds. If you want to find out why December 2023 was the month for the gene editing industry, then check out 12 Most Promising Gene Editing Stocks According to Hedge Funds.

5. Exact Sciences Corporation (NASDAQ:EXAS)

Number of Hedge Fund Investors In Q3 2023: 45

Exact Sciences Corporation (NASDAQ:EXAS) is an American company that sells DNA testing products and kits. It is one of the top rated stocks on our list as analysts have rated the shares as Strong Buy on average and set an average share price target of $92.82.

During Q3 2023, 45 out of the 910 hedge funds part of Insider Monkey’s database held a stake in Exact Sciences Corporation (NASDAQ:EXAS). Catherine D. Wood’s ARK Investment Management was the firm’s largest shareholder as it held 6.2 million shares that were worth $428 million.